Evidence map›Paper›PMID 31019504›Full record

ArticleFrontiers in immunology2019

Necroptotic Cell Death Promotes Adaptive Immunity Against Colonizing Pneumococci.

Ashleigh Nichole Riegler, Terry Brissac, Norberto Gonzalez-Juarbe, Carlos J Orihuela

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Necroptosis in bacterial infections.Frontiers in immunology · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ashleigh Nichole RieglerDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States.
Terry BrissacDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States.
Norberto Gonzalez-JuarbeDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States.
Carlos J OrihuelaDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States.
University of Alabama at Birmingham · US

Funding

IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
Inhibition of necroptosis during inflamm-aging and pneumoniaR21AG055144 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ORIHUELA, CARLOS J · 2016 to 2017
$404k
NIAID NIH HHS R01 AI114800NIAID NIH HHS T32 AI007051NIA NIH HHS R21 AG055144
6 · The paper itself

Abstract

Pore-forming toxin (PFT) induced necroptosis exacerbates pulmonary injury during bacterial pneumonia. However, its role during asymptomatic nasopharyngeal colonization and toward the development of protective immunity was unknown. Using a mouse model of

Indexed as

Adaptive ImmunityAnimalsAntibody FormationApoptosisBacterial ProteinsDisease Models, AnimalEpithelial CellsFemaleHumansImmunity, InnateMaleMiceNecroptosisPneumococcal InfectionsStreptococcus pneumoniaeStreptolysinsBacterial ProteinsplY protein, Streptococcus pneumoniaeStreptolysinscell deathcolonizationinnate and adaptive immune responsenecroptosisnecrosispneumolysin (PLY)pore-forming toxin (PFT)Streptococcus pneumoniae

Identifiers

PMID31019504
PMCPMC6459137
OpenAlexW2927161796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.